Literature DB >> 29671064

The relationship between the central serous chorioretinopathy, choroidal thickness, and serum hormone levels.

Emine Çiloğlu1,2, Fikret Unal3, Nese Cetin Dogan3.   

Abstract

PURPOSE: The purpose of this study were to compare the levels of serum cortisol, aldosterone, testosterone, dehydroepiandrosterone (DHEA), and renin hormone between patients with central serous chorioretinopathy (CSC) and a control group, and to investigate whether there was a difference regarding serum hormone levels in patients with acute/chronic CSC.
METHODS: This prospective study included 30 CSC eyes, 30 fellow eyes, and 32 normal eyes of 32 healthy volunteers who were age and sex matched. The patients were classified as acute or chronic depending on the clinical, fluorescein angiography (FFA), and optical coherence tomography (OCT) findings. Serum cortisol, aldosterone, renin, total testosterone, and DHEA levels were measured. The levels of hormones were compared with the values of the control group. Choroidal thickness and central macular thickness were measured with spectral domain OCT.
RESULTS: Fifteen patients had acute CSC, and 15 patients had chronic CSC. Serum testosterone levels were 357 ± 10.4 ng/ml in the CSC group, and 255.94 ± 7.43 ng/ml in the control group. The difference between them was statistically significant (p < 0.001). The difference between the levels of cortisol, renin, aldosterone, and DHEA was not statistically significant. Serum hormone levels were within the normal range for all patients and were not statistically different between the acute and chronic CSC groups.
CONCLUSION: According to our results, CSC is related to elevated total testosterone levels. Testosterone may play a role in predisposing males to CSC.

Entities:  

Keywords:  Aldosterone; Central serous chorioretinopathy; Cortisol; Renin; Testosterone

Mesh:

Substances:

Year:  2018        PMID: 29671064     DOI: 10.1007/s00417-018-3985-x

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  36 in total

1.  Central serous chorioretinopathy associated with a carcinoma of the adrenal cortex.

Authors:  A M Thoelen; P P Bernasconi; C Schmid; E P Messmer
Journal:  Retina       Date:  2000       Impact factor: 4.256

Review 2.  Idiopathic central serous chorioretinopathy.

Authors:  D Hussain; J D Gass
Journal:  Indian J Ophthalmol       Date:  1998-09       Impact factor: 1.848

3.  Identification of androgen receptor protein and 5alpha-reductase mRNA in human ocular tissues.

Authors:  E M Rocha; L A Wickham; L A da Silveira; K L Krenzer; F S Yu; I Toda; B D Sullivan; D A Sullivan
Journal:  Br J Ophthalmol       Date:  2000-01       Impact factor: 4.638

4.  [Experimental serous choroidopathy (author's transl)].

Authors:  S Watanabe; K Ohtsuki
Journal:  Nippon Ganka Gakkai Zasshi       Date:  1979-07-10

5.  Serum dehydroepiandrosterone sulphate, total antioxidant capacity, and total oxidant status in central serous chorioretinopathy.

Authors:  Fatih Mehmet Türkcü; Harun Yüksel; Hatice Yüksel; Alparslan Sahin; Yasin Cinar; Abdullah Kürşat Cingü; Muhammed Sahin; Ihsan Caça
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-06-08       Impact factor: 3.117

6.  The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980-2002.

Authors:  Anna S Kitzmann; Jose S Pulido; Nancy N Diehl; David O Hodge; James P Burke
Journal:  Ophthalmology       Date:  2008-01       Impact factor: 12.079

7.  Digital indocyanine green videoangiography of central serous chorioretinopathy.

Authors:  D R Guyer; L A Yannuzzi; J S Slakter; J A Sorenson; A Ho; D Orlock
Journal:  Arch Ophthalmol       Date:  1994-08

8.  CENTRAL SEROUS CHORIORETINOPATHY IN POSTMENOPAUSAL WOMEN RECEIVING EXOGENOUS TESTOSTERONE.

Authors:  Mandi D Conway; Jason A Noble; Gholam A Peyman
Journal:  Retin Cases Brief Rep       Date:  2017 Spring

9.  Comparison of Serum Cortisol and Testosterone Levels in Acute and Chronic Central Serous Chorioretinopathy.

Authors:  Tanie Natung; Avonuo Keditsu
Journal:  Korean J Ophthalmol       Date:  2015-11-25

10.  Serum cortisol and testosterone levels in idiopathic central serous chorioretinopathy.

Authors:  Shaik M Zakir; M Shukla; Zaka-Ur-Rab Simi; J Ahmad; Mahmood Sajid
Journal:  Indian J Ophthalmol       Date:  2009 Nov-Dec       Impact factor: 1.848

View more
  7 in total

1.  Distinct characteristics of central serous chorioretinopathy according to gender.

Authors:  Seigo Yoneyama; Ayumi Fukui; Yoichi Sakurada; Nobuhiro Terao; Taiyo Shijo; Natsuki Kusada; Atsushi Sugiyama; Mio Matsubara; Yoshiko Fukuda; Wataru Kikushima; Ravi Parikh; Fumihiko Mabuchi; Chie Sotozono; Kenji Kashiwagi
Journal:  Sci Rep       Date:  2022-06-22       Impact factor: 4.996

2.  Effects of Ketoconazole on the Clinical Recovery in Central Serous Chorioretinopathy.

Authors:  Yodpong Chantarasorn; Kochapong Rasmidatta; Itsara Pokawattana; Sukhum Silpa-Archa
Journal:  Clin Ophthalmol       Date:  2022-06-09

3.  Risk Factors for Persistent or Recurrent Central Serous Chorioretinopathy.

Authors:  Jia Yu; Gezhi Xu; Qing Chang; Xiaofeng Ye; Lei Li; Chunhui Jiang; Qi Zhao
Journal:  J Ophthalmol       Date:  2019-08-14       Impact factor: 1.909

4.  Ciliochoroidal effusion syndrome with central serous-like chorioretinopathy and secondary angle closure following exogenous testosterone use.

Authors:  Daniel Brill; Desiree Albert; Taylor Fields; Shravani Mikkilineni; David Crandall; Hua Gao
Journal:  Am J Ophthalmol Case Rep       Date:  2019-06-05

5.  Central Serous Chorioretinopathy and Blood Serotonin Concentrations.

Authors:  Takeshi Kimura; Takashi Araki; Yuki Komuku; Hisashi Iwami; Fumi Gomi
Journal:  J Clin Med       Date:  2021-02-03       Impact factor: 4.241

6.  The Association Between Circulating Sex Hormones and Central Serous Chorioretinopathy: A Case-Control Study.

Authors:  Chun Zhao; Yan Huang; Xiao-Qiang Liu; Lei Chen; Sheng Ye
Journal:  Ther Clin Risk Manag       Date:  2022-08-25       Impact factor: 2.755

7.  Clinical Characteristics and Multimodal Imaging Findings of Central Serous Chorioretinopathy in Women versus Men.

Authors:  Elodie Bousquet; Héloïse Torres-Villaros; Julien Provost; Martine Elalouf; Anthony Gigon; Irmela Mantel; Aurélie Timsit; Francine Behar-Cohen
Journal:  J Clin Med       Date:  2022-03-19       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.